Oklahoma City, OK Lawyers

Rezulin

In March 2000 the FDA advised that the "continued use of Rezulin" posed an "unacceptable risk " to diabetes patients. At least 63 Rezulin users have died of liver failure. Some estimates suggest the actual number of deaths is ten times higher than the reported cases.

Rezulin was banned in England in December 1997, following the death of an American who took the drug. The drug manufacturer, Warner-Lambert, successfully fought a ban in the U.S. for more than two years before the FDA prohibited sales of Rezulin on March 2000. Before the ban, sales of Rezulin generated Warner-Lambert $1.8 billion in revenues. At its peak, the drug was prescribed 488,000 times in January of 1999.

The recall only came after an FDA whistle blower shared his findings and internal FDA email messages with an L.A. Times reporter. This information and interviews with several doctors led to a series of articles in the Los Angeles Times discussing the dangers of Rezulin. The articles also raised questions about the FDA's irregular "fast track" approval of Rezulin.

The Rezulin litigation has resulted in a multimillion dollar settlement for the benefit of the injured victims and the families of people who died of liver failure.

If you or a loved one has been injured by Rezulin or any other defective drug, please call the Oklahoma Rezulin lawyers at Cunningham & Mears, P.C. We'll fight the drug companies and make sure you get the settlement you deserve.